Status:
COMPLETED
Treatment of the Overactive Bladder Syndrome: A Delphi Study
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Astellas Pharma Inc
Medtronic
Conditions:
Overactive Bladder Syndrome
Eligibility:
All Genders
Brief Summary
Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even guidelines are n...
Detailed Description
Guidelines on the overactive bladder syndrome (European Association of Urology, American Urology Association and International Consultation on Incontinence) are comparable but remain vague mainly on t...
Eligibility Criteria
Inclusion
- Profession: MD, Urologist
- Member of the working group of Functional Urology
Exclusion
- Retirement
- Non-operative as an urologist.
Key Trial Info
Start Date :
October 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 10 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04300400
Start Date
October 16 2018
End Date
September 10 2019
Last Update
January 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, East-Flanders, Belgium, 9000